Evidence map›Paper›PMID 30510068›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Alexander M S Barron, Julio C Mantero, Jonathan D Ho, Banafsheh Nazari, Katharine L Horback, Jag Bhawan, Robert Lafyatis, Christina Lam, Jeffrey L Browning

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Role and mechanism of CD90Molecular medicine (Cambridge, Mass.) · 2023
    Review
  7. Article
  8. Review
  9. CD105Scientific reports · 2021
    Article
  10. Lung-resident memory B cells protect against bacterial pneumonia.The Journal of clinical investigation · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alexander M S BarronDepartment of Microbiology, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0001-5962-553X
Julio C ManteroDepartment of Microbiology, Boston University School of Medicine, Boston, MA 02118.
Jonathan D HoDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0002-8752-8769
Banafsheh NazariSection of Rheumatology, Boston University School of Medicine, Boston, MA 02118.
Katharine L HorbackDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; and.
Jag BhawanDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0001-9264-7300
Robert LafyatisSection of Rheumatology, Boston University School of Medicine, Boston, MA 02118.
Christina LamDepartment of Dermatology, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0002-4761-5163
Jeffrey L BrowningDepartment of Microbiology, Boston University School of Medicine, Boston, MA 02118; browninj@gmail.com.ORCID 0000-0001-9168-5233
Boston University · USBrigham and Women's Hospital · US

Funding

Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesisP50AR060780 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LAFYATIS, ROBERT A. · 2011 to 2021
$14.9M
RESEARCH TRAINING IN IMMUNOLOGYT32AI007309 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 1988 to 2024
$7.4M
Rheumatic Diseases Research Core CentersP30AR061271 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LAFYATIS, ROBERT A., SIMMS, ROBERT W · 2011 to 2015
$3.1M
NIAID NIH HHS T32 AI007309NIAMS NIH HHS P30 AR061271NIAMS NIH HHS P50 AR060780
6 · The paper itself

Abstract

Perivascular accumulation of lymphocytes can be a prominent histopathologic feature of various human inflammatory skin diseases. Select examples include systemic sclerosis, spongiotic dermatitis, and cutaneous lupus. Although a large body of work has described various aspects of the endothelial and vascular smooth muscle layers in these diseases, the outer adventitial compartment is poorly explored. The goal of the current study was to characterize perivascular adventitial fibroblast states in inflammatory human skin diseases and relate these states to perivascular lymphocyte accumulation. In normal skin, adventitial fibroblasts are distinguished by CD90 expression, and dense perivascular lymphocytic infiltrates are uncommon. In systemic sclerosis, this compartment expands, but lymphocyte infiltrates remain sparse. In contrast, perivascular adventitial fibroblast expression of VCAM1 is upregulated in spongiotic dermatitis and lupus and is associated with a dense perivascular T cell infiltrate. VCAM1 expression marks transitioned fibroblasts that show some resemblance to the reticular stromal cells in secondary lymphoid organs. Expanded adventitial compartments with perivascular infiltrates similar to the human settings were not seen in the inflamed murine dermis. This species difference may hinder the dissection of aspects of perivascular adventitial pathology. The altered perivascular adventitial compartment and its associated reticular network form a niche for lymphocytes and appear to be fundamental in the development of an inflammatory pattern.

Indexed as

AdultAgedAged, 80 and overCells, CulturedDermatitisFemaleFibroblastsHumansInflammationLupus Erythematosus, DiscoidMaleMiddle AgedScleroderma, SystemicSkinThy-1 AntigensT-LymphocytesThy-1 AntigensVascular Cell Adhesion Molecule-1

Identifiers

PMID30510068
PMCPMC6305793
OpenAlexW2902045628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.